09.02.2015 • NewsAlexander HaunschildBASFCoatings

BASF to Lift Chromate Pigment Capacities

BASF plans to "significantly increase" production capacities for bismuth vanadate pigments at Besigheim, Germany, near Stuttgart, from 2017.

The German chemical giant markets the yellow pigments with a special greenish color tone used to formulate paints and coatings under the Sicopal and Paliotan brand names.

BASF said its bismuth vanadate pigments are a high performance inorganic alternative to pigments containing lead chromate, which, according to the EU chemicals legislation REACh are classified as CMR substances (carcinogenic, mutagenic or toxic for reproduction).

"Over the next few years we expect our customers' demand for bismuth vanadate pigments to grow faster than the overall pigment market, both in Europe and worldwide. By expanding the production capacities we are responding to this increase in demand," said Alexander Haunschild, senior vice president of BASF's business unit Pigments & Resins Europe.

Starting this year, BASF will no longer produce pigments containing lead chromate. "We are committed to offering our customers innovative products that enable them to develop sustainable solutions," Haunschild stressed.

BASF regards itself as one of the global market leaders in bismuth vanadate pigments. In 2015, it plans to introduce a newly developed alkali-stable bismuth vanadate pigment for the formulation of paints as well as a temperature-stable bismuth vanadate pigment for plastic applications.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.